Editorial Commentary:Persistent Clinical Impact of Cytomegalovirus in Organ Transplantation
Open Access
- 1 October 2008
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 47 (7) , 883-884
- https://doi.org/10.1086/591533
Abstract
In 1979, Henry Balfour termed cytomegalovirus (CMV) the “troll of transplantation” for the way CMV unwittingly sneaks up on a successful transplant recipient and either precipitates one of its many indirect effects or directly harms the patient [1]. Although we have decreased, rather dramatically, the clinical impact of CMV on organ transplantation [2, 3], with dramatic improvement in patient and graft survival, we know that CMV infection and disease still occur, as is nicely illustrated in the article by San Juan et al. [4] in this issue of the Clinical Infectious Diseases.Keywords
This publication has 18 references indexed in Scilit:
- Valganciclovir as Treatment for Cytomegalovirus Disease in Solid Organ Transplant RecipientsClinical Infectious Diseases, 2008
- Human cytomegalovirus infection alters the substrate specificities and rapamycin sensitivities of raptor- and rictor-containing complexesProceedings of the National Academy of Sciences, 2006
- Valganciclovir Preemptive Therapy for the Prevention of Cytomegalovirus Disease in High-Risk Seropositive Solid-Organ Transplant RecipientsTransplantation, 2006
- 24-Week Oral Ganciclovir Prophylaxis in Kidney Recipients Is Associated with Reduced Symptomatic Cytomegalovirus Disease Compared to a 12-Week CourseTransplantation, 2006
- Allograft Rejection Predicts the Occurrence of Late‐Onset Cytomegalovirus (CMV) Disease among CMV‐Mismatched Solid Organ Transplant Patients Receiving Prophylaxis with Oral GanciclovirThe Journal of Infectious Diseases, 2001
- Epidemiology of Infections after Solid?Organ TransplantationClinical Infectious Diseases, 2001
- Risk factors for cytomegalovirus and severe bacterial infections following liver transplantation: a prospective multivariate time-dependent analysisJournal of Hepatology, 1993
- SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2Transplantation, 1992
- Use of Cytomegalovirus Immune Globulin to Prevent Cytomegalovirus Disease in Renal-Transplant RecipientsNew England Journal of Medicine, 1987
- Cytomegalovirus: the troll of transplantationArchives of internal medicine (1960), 1979